BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2138649)

  • 1. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1987 Jun; 138(12):4085-92. PubMed ID: 2438333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allostimulatory analysis of a newly-defined and widely-distributed Mls superantigen.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    Immunogenetics; 1991; 34(2):88-100. PubMed ID: 1714422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell recognition of Mlsc,x determinants.
    Abromson-Leeman SR; Laning JC; Dorf ME
    J Immunol; 1988 Mar; 140(6):1726-31. PubMed ID: 3126235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Mls determinants in mice exhibiting the severe combined immunodeficiency (scid) mutation or X-linked immunodeficiency (xid) defect.
    Roberts JL; Abe R; Shores EW; Singer A
    J Immunol; 1992 Sep; 149(5):1577-82. PubMed ID: 1506683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition.
    Abe R; Hodes RJ
    J Immunol; 1988 Jun; 140(12):4132-8. PubMed ID: 2453568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal analysis of the Mls system. A reappraisal of polymorphism and allelism among Mlsa, Mlsc, and Mlsd.
    Abe R; Ryan JJ; Hodes RJ
    J Exp Med; 1987 Apr; 165(4):1113-29. PubMed ID: 2435833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell recognition of Mls. T cell clones demonstrate polymorphism between Mlsa, Mlsc, and Mlsd.
    Abe R; Ryan JJ; Finkelman FD; Hodes RJ
    J Immunol; 1987 Jan; 138(2):373-9. PubMed ID: 2432122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor lymphocyte stimulating (Mls) gene products in mice influence their genetic resistance or susceptibility to induction of autoimmune encephalomyelitis.
    Ben-Nun A; Soffer D
    Eur J Immunol; 1990 Jan; 20(1):195-200. PubMed ID: 1689661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell responses to Mls determinants are restricted by cross-reactive MHC determinants.
    Lynch DH; Gress RE; Needleman BW; Rosenberg SA; Hodes RJ
    J Immunol; 1985 Apr; 134(4):2071-8. PubMed ID: 2579127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
    Janeway CA; Katz ME
    J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Mls-reactive T cells in H-2-compatible but Mls-incompatible bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsumoto K; Sakumoto M; Matsuzaki G; Nomoto K
    Eur J Immunol; 1989 Jun; 19(6):1009-13. PubMed ID: 2502418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectionality of mixed lymphocyte stimulation (Mls) response. Effects of Mlsb stimulator cells on Mlsa helper cells.
    Hämmerling U; Toulon M; Chun M; Palfree S; Hoffmann MK
    J Immunol; 1988 Apr; 140(8):2543-8. PubMed ID: 2965723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes.
    Pullen AM; Marrack P; Kappler JW
    J Immunol; 1989 May; 142(9):3033-7. PubMed ID: 2496158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants.
    DeKruyff RH; Ju ST; Laning J; Cantor H; Dorf ME
    J Immunol; 1986 Aug; 137(4):1109-14. PubMed ID: 2426352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.